Effects of Panax ginseng on Health-Related Quality of Life in patients with non-metastatic breast cancer: Arandomized, double-blind, placebo-controlled clinical trial
Publish place: 15th International Congress of Breast Cancer
Publish Year: 1400
نوع سند: مقاله کنفرانسی
زبان: English
View: 245
نسخه کامل این Paper ارائه نشده است و در دسترس نمی باشد
- Certificate
- من نویسنده این مقاله هستم
این Paper در بخشهای موضوعی زیر دسته بندی شده است:
استخراج به نرم افزارهای پژوهشی:
شناسه ملی سند علمی:
ICBCMED15_009
تاریخ نمایه سازی: 28 شهریور 1401
Abstract:
Being diagnosed with breast cancer in parallelwith chemotherapy impose distressing symptomson patients' Health-Related Quality of Life(HRQOL). This prospective study evaluated theimpact of ginseng supplementation on improvingmultiple aspects of HRQOL in breast cancerpatients.Forty women with non-metastatic early breastcancer were enrolled in the study. Participantsreceived ginseng (۱ g/day) or placebo inconjunction with standard anticancer therapy.HRQOL was evaluated via in-person interviewsat baseline, two weeks after the second and lastchemotherapy cycles. The FACT-B, a ۳۷-itemquestionnaire composed of five subscalesincluding physical well-being (PWB), social wellbeing(SWB), emotional well-being (EWB),functional well-being (FWB), and Breast CancerSubscale (BCS) was employed for assessmentof HRQOL.
Keywords:
Authors
Malihe Hamidian
registeredin the Iranian Registry of Clinical Trials (IRCT,IRCT۲۰۱۴۱۲۲۷۰۲۰۴۴۱N۷) and was financiallysupported by Shiraz University of MedicalSciences, Shiraz, Iran